drugset / Trial / NCT00843011

Food and Relative Bioavailability Study

NCT00843011 ↗

Phase 1 Completed 14 enrolled GlaxoSmithKline
RandomizedCrossoverOpen-labelTreatment

Summary

This study is an open-label, randomised, single dose study to determine the pharmacokinetics, safety and tolerability of 2 different formulations of orvepitant 60 mg and the effect of food in 15 Healthy Volunteers.

Timeline

Start
2008-08-28
Primary completion
2008-10-23
Completion
2008-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Orvepitant Small molecule 60 mg —

Indications